Veterans’ RightsAn independent resource for veterans
← All decisions
Denied

The Veteran's prostate cancer residuals have been rated at a maximum of 60 percent since July 13, 2023. The Board denied an increased rating as the evidence does not support a higher rating based on predominant voiding dysfunction.

The deciding factor: The Veteran's prostate cancer residuals predominantly manifest as voiding dysfunction, which is already rated at its maximum under DC 7528.

Claimed conditions
Prostate Cancer
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
60%
Decision date
September 19, 2023
Citation
23051650

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 23051650.

What this means for you

A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.